Stock Taper
SCREENER COMPARE ANY 2 STOCKS
VRPX
VIRPAX PHARMACEUTICALS, INC.
OTC
$0.00
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$249.00
52w High$0.10
52w Low$0.00
Dividend Yield—
Frequency—
P/E—
Volume51
Shares Out.1.24M

COMPANY

LEADERSHIP

Jatinder Dhaliwal
CHIEF EXECUTIVE
Jatinder Dhaliwal

COMPENSATION 2026

Salary$445,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$711,000
Total$1,216,000

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 17, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
2

PRICE TARGET

Target High$3.00
Target Low$3.00
Target Median$3.00
Target Consensus$3.00

UPCOMING EARNINGS

DateNov 19, 2026
DayThursday
Rev. Est.—
NOV
19
THU

SPLIT RECORD

DATETYPERATIO
2025-03-21Reverse1:25
2024-03-01Reverse1:10

PRICE

$0.00 ▲ UP 0.00% (+$0.00)
OVERLAYS
$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.0011:48 AM12:13 PM12:38 PM1:03 PM1:29 PM1:54 PM2:19 PM0.00

About Virpax Pharmaceuticals, Inc.

https://www.virpaxpharma.com ↗

Virpax Pharmaceuticals, Inc. develops preclinical drug-delivery systems and technologies for non-opioid pain management and CNS disorders, including topical, injectable, and nasal formulations targeting osteoarthritis, postoperative pain, viral in...

INDUSTRY

Biotechnology

A PRODUCT VIRPAX PHARMACEUTICALS, INC. IS KNOWN FOR

Probudur™
Probudur™

Probudur™ is a long-acting liposomal bupivacaine injectable developed by Virpax to provide up to 96 hours of post-operative pain relief, potentially reducing opioid use, in collaboration with the U.S. Army Institute of Surgical Research.

COMPETITORS

COMPETITOR
COLL COMPARE
HRTX COMPARE
PCRX COMPARE
VRTX COMPARE

SECTORS PEERS

PEERPRICE
PIII$10.31COMPARE
AKTX$7.85COMPARE
REVB$1.09COMPARE
ACON$2.71COMPARE
DRMA$1.42COMPARE
PPBT$1.57COMPARE
VINC$0.01COMPARE
SLXNW$0.01COMPARE